BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative ...
Reports, features, opinion and analysis about Ireland and the world from leading academics and researchers on RTÉ Brainstorm ...
BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the three months ended March ...
Former Senior FDA Official Joins Board as Company Prepares to Initiate Historic Phase 3b ALS Trial Under Special Protocol Assessment NEW YORK, May 28, 2026 /PRNewswire/ -- BrainStorm Cell ...
Brainstorm Cell Therapeutics Inc., a biotechnology company, is dedicated to the development and commercialization of autologous cell therapies for the treatment of neurodegenerative diseases. The ...
BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results